|View printer-friendly version|
|Elizabeth Arden, Inc. Announces First Quarter Fiscal 2009 Results|
NEW YORK, Nov 6, 2008 (GlobeNewswire via COMTEX News Network) -- Elizabeth Arden, Inc. (Nasdaq:RDEN), a global prestige beauty products company, today announced financial results for its first fiscal quarter ended September 30, 2008.
FIRST QUARTER RESULTS
For the first fiscal quarter ended September 30, 2008, net sales rose 4.6% to $284.2 million. Excluding the unfavorable impact of foreign currency translation, net sales increased 4.8% as compared to the prior year period.
Net income for the first fiscal quarter ended September 30, 2008, excluding expenses related to the recent Liz Claiborne license agreement and restructuring expenses, was $3.1 million, or $0.11 per diluted share, versus net income, excluding restructuring expenses, of $1.1 million, or $0.04 per diluted share, for the prior year period. On a reported basis, net loss for the first quarter of fiscal 2009 was $12.5 million, or $0.45 per share, compared to net income of $0.4 million, or $0.01 per share, for the prior year period.
E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, "We were pleased with our results this quarter, which were essentially on plan, particularly given the global economic weakness and foreign currency volatility. Net sales of our North America fragrance business increased by 9%, driven largely by the contribution from the Liz Claiborne brands and our new launches. The integration of the Liz Claiborne fragrance business has gone very well and is nearly complete. Our new launches, including new fragrance brands from Juicy Couture, Usher and Mariah Carey, as well as the Rocawear 9IX fragrance, performed well. Prevage Body was also introduced in the U.S. this quarter, which led to a 27% increase in net sales of the Prevage franchise. Net sales of our international business rose by 1%, which was on top of an 18% increase in the first quarter of the prior year."
Mr. Beattie continued, "We also continue to make progress with our supply chain and re-engineering initiatives, which contributed to our improved operating performance this quarter. Gross margins (adjusted for Liz Claiborne-related expenses) and operating cash flow improved this quarter, and despite the incremental Liz Claiborne inventory purchased in June in connection with the license agreement, we only had a slight increase in inventory levels as compared to the first fiscal quarter of the prior year. We remain on track with the execution of these initiatives, which are even more important in this difficult economic environment."
In July 2008, the Company increased its credit facility, which expires in December 2012, to $325 million from $250 million. The Company believes it has ample liquidity to finance its ongoing working capital, capital expenditure and other requirements for the foreseeable future. The Company's borrowings under its credit facility peaked in October and borrowing availability as of the end of October 2008 was $56.0 million.
The Company's $80 million common stock repurchase plan was set to expire on November 30, 2008. As such, on November 5, 2008, the Company's Board of Directors authorized the extension of its common stock repurchase plan at the same $80 million limit to November 30, 2010. Under the program, the Company may, from time to time, purchase shares of its common stock in the open market or in privately negotiated transactions based on such factors as the Company deems appropriate. To date, the Company has repurchased $41.3 million of common stock under its $80 million stock repurchase plan.
Given the challenging consumer and retail environment worldwide and the impact of foreign currency fluctuations, the Company is revising its fiscal 2009 guidance for the first half and full fiscal year. The Company currently expects reported net sales to increase by 1.0% to 3.5% for the first half of fiscal 2009 and to increase by 6.5% to 8.5% for the full fiscal year. Excluding the unfavorable impact of foreign currency translation, the Company expects net sales to increase by 3.5% to 6.0% for the first half of fiscal 2009 and by 9.5% to 11.5% for the full fiscal year, assuming current rates.
The Company expects diluted earnings per share to range between $1.18 to $1.28 for the first half of fiscal 2009 and to range between $1.50 and $1.75 for the full fiscal year, excluding an expected unfavorable impact from foreign currency translation of $0.18 for the first half of fiscal 2009 and $0.08 for the full fiscal year, assuming current rates. This compares to original guidance of $1.28 to $1.40 for the first half of fiscal 2009 and $1.65 to $1.85 for the full fiscal year.
The guidance assumes current rates in effect as of the end of October 2008 and excludes expenses related to the Liz Claiborne license agreement and restructuring charges associated with the Company's extended supply chain, logistics and transaction processing re-engineering project. As previously disclosed, the Company's reported gross margins for the first half of fiscal 2009 will be impacted by non-cash expenses related to the Liz Claiborne inventory purchased by the Company at a higher cost prior to the effective date of the license agreement. The Company recorded $15.4 million of these non-cash expenses (pre-tax) in the quarter ended September 30, 2008 and expects to incur $3.6 million in the second fiscal quarter ending December 31, 2008.
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company's conference call by visiting the "Corporate Info" section on the Company's web site at http://www.elizabetharden.com. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Company's web site until December 6, 2008.
Elizabeth Arden is a global prestige beauty products company with an extensive portfolio of prestige beauty brands sold in over 90 countries. The company's brand portfolio includes Elizabeth Arden skincare, color, and fragrance products, PREVAGE(r) anti-aging treatments, the celebrity fragrance brands of Elizabeth Taylor, Mariah Carey, Britney Spears, Hilary Duff, Danielle Steel, and Usher; the designer fragrance brands of Juicy Couture, Alberta Ferretti, Alfred Sung, Badgley Mischka, Bob Mackie, GANT, Geoffrey Beene, Liz Claiborne, Halston, Lucky Brand, Nanette Lepore and Rocawear; and the lifestyle fragrance brands Curve, Giorgio Beverly Hills, and PS Fine Cologne.
ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited) (In thousands, except percentages and per share data) Three Months Ended ------------------------ Sept. 30, Sept. 30, 2008 2007 -------- -------- Net Sales $284,187 $271,789 Cost of Sales 177,773 165,408 -------- -------- Gross Profit 106,414 106,381 Gross Profit Percentage 37.4 % 39.1% Selling, General and Administrative Expenses 109,388 92,472 Depreciation and Amortization 6,339 5,954 -------- -------- Total Operating Expenses 115,727 98,426 Interest Expense, Net 6,575 7,488 -------- -------- (Loss) Income Before Income Taxes (15,888) 467 (Benefit from) Provision for Income Taxes (3,372) 117 -------- -------- Net (Loss) Income $(12,516) $ 350 ======== ======== As reported: ---------------------------------------- Net (Loss) Income Per Basic and Diluted Share $ (0.45) $ 0.01 Basic Shares 27,866 27,883 Diluted Shares 27,866 29,390 EBITDA (a) $ (2,974) $ 13,909 EBITDA margin (1.0)% 5.1% Adjusted to exclude the effect of Liz Claiborne-related and restructuring expenses, net of taxes (b)(c): ---------------------------------------- Gross Profit $122,809 $106,381 Gross Profit Percentage 43.2% 39.1% Net Income $ 3,128 $ 1,061 Net Income Per Basic And Diluted Share $ 0.11 $ 0.04 EBITDA (a) $ 17,256 $ 14,856 EBITDA margin 6.1% 5.5% (a) EBITDA is defined as net income plus the provision for income taxes (or net loss less benefit from income taxes), plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to (loss) income from operations or net (loss) income (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures. EBITDA margin represents EBITDA divided by Net Sales. We have also disclosed EBITDA as adjusted to reflect the effect of Liz Claiborne- related and restructuring expenses. This disclosure is being provided for comparability purposes because we believe it is meaningful to our inventors and other interested parties to understand the EBITDA performance of the Company on a consistent basis without regard to the effect of Liz Claiborne-related and restructuring expenses. EBITDA margin represents EBITDA divided by Net Sales.
The table below reconciles net (loss) income, as determined in accordance with GAAP, to EBITDA and to EBITDA as adjusted: (For a reconciliation of net income (loss) to EBITDA for prior periods, seethe Company's filings with the Securities and Exchange Commission which can be found on the Company's website at www.elizabetharden.com).
(In thousands) Three Months Ended ------------------------ Sept. 30, Sept. 30, 2008 2007 -------- -------- Net (loss) income $(12,516) $ 350 Plus: (Benefit from) provision for income taxes (3,372) 117 Interest expense, net 6,575 7,488 Depreciation and amortization 6,339 5,954 -------- -------- EBITDA (2,974) 13,909 Liz Claiborne-related expenses (c) 19,091 -- Restructuring expenses 1,139 947 -------- -------- EBITDA as adjusted $ 17,256 $ 14,856 ======== ======== (b) The table below reconciles the calculation of (i) gross profit (ii) net (loss) income and (iii) net (loss) income per share on a basic and diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to Liz Claiborne-related and restructuring expenses. This disclosure is being provided for comparability purposes because we believe it is meaningful to our investors and other interested parties to understand the Company's operating performance on a consistent basis without regard to the effect of Liz Claiborne-related and restructuring expenses. The presentation in the table below of the non-GAAP information titled "Gross profit as adjusted" and "Net income as adjusted" and "Net income per basic and diluted share as adjusted" is not meant to be considered in isolation or as a substitute for gross profit, net (loss) income or net (loss) income per basic and diluted share prepared in accordance with GAAP. (In thousands, except per share data) Three Months Ended ------------------------ Sept. 30, Sept. 30, 2008 2007 -------- -------- Adjusted to exclude the effect of Liz Claiborne-related and restructuring expenses ---------------------------------------- Gross Profit: ------------- Gross profit as reported $106,414 $106,381 Liz Claiborne-related expenses (c) 16,395 -- -------- -------- Gross profit as adjusted $122,809 $106,381 ======== ======== Net (Loss) Income: ------------------ Net (loss) income as reported $(12,516) $ 350 Liz Claiborne-related expenses, net of tax 14,763 -- Restructuring expenses, net of tax (c) 881 711 -------- -------- Net income as adjusted $ 3,128 $ 1,061 ======== ======== Net (Loss) Income Per Basic And Diluted Share: ------------------------------- Net (loss) income per basic and diluted share as reported $ (0.45) $ 0.01 Liz Claiborne-related and restructuring expenses, net of tax (c) 0.56 0.03 -------- -------- Net income per basic and diluted share as adjusted $ 0.11 $ 0.04 ======== ======== (c) Includes $3.7 million of Liz Claiborne transition expenses and $15.4 million of non-cash expenses relating to Liz Claiborne inventory purchased by the Company at a higher cost prior to the effective date of the license agreement. Approximately $1.0 million of transition expenses are included in cost of sales. SEGMENT NET SALES
The table below is a comparative summary of our net sales by reportable segment for the three months ended September 30, 2008 and2007:
(In thousands) Three Months Ended ------------------------ Sept. 30, Sept. 30, 2008 2007 -------- -------- Segment Net Sales: North America Fragrance $177,560 $162,858 International 94,426 93,795 Other 12,201 15,136 -------- -------- Total $284,187 $271,789 ======== ======== ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEET DATA (Unaudited) (In thousands) September 30, June 30, September 30, 2008 2008 2007 ---------- ---------- ---------- Cash $ 27,518 $ 26,396 $ 27,152 Accounts Receivable, Net 290,723 217,446 275,278 Inventories 458,711 408,563 450,071 Property and Equipment, Net 50,714 52,148 44,027 Exclusive Brand Licenses, Trademarks and Intangibles, Net 220,785 221,253 222,329 Total Assets 1,109,191 970,734 1,072,226 Short-Term Debt 229,500 119,000 223,000 Current Portion of Long-Term Debt 1,205 1,261 1,252 Current Liabilities 531,006 385,934 497,486 Long-Term Liabilities 243,418 248,199 255,781 Total Debt 453,856 343,957 448,384 Shareholders' Equity 334,767 336,601 318,959 Working Capital 300,549 305,863 302,077
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding net sales and earnings, and the costs, savings and benefits we expect in connection with our re-engineering project and related restructuring plan. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended June 30, 2008.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Elizabeth Arden, Inc.
Elizabeth Arden, Inc.